S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
ACB   3.71 (-4.63%)
NFLX   275.30 (-6.15%)
BAC   30.45 (+0.63%)
GILD   64.23 (-1.53%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
ACB   3.71 (-4.63%)
NFLX   275.30 (-6.15%)
BAC   30.45 (+0.63%)
GILD   64.23 (-1.53%)
Log in

Eyegate Pharmaceuticals News Headlines (NASDAQ:EYEG)

$3.35
+0.04 (+1.21 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$3.31
Now: $3.35
$3.45
50-Day Range
$0.17
MA: $3.09
$3.80
52-Week Range
$2.25
Now: $3.35
$9.60
Volume2,937 shs
Average Volume17,890 shs
Market Capitalization$10.23 million
P/E RatioN/A
Dividend YieldN/A
Beta2.12

Headlines

Eyegate Pharmaceuticals (NASDAQ EYEG) News Headlines

Source:
DateHeadline
Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) Short Interest UpdateEyegate Pharmaceuticals Inc (NASDAQ:EYEG) Short Interest Update
www.americanbankingnews.com - October 12 at 7:47 PM
EyeGate Pharma launches follow-on PE pilot studyEyeGate Pharma launches follow-on PE pilot study
seekingalpha.com - October 9 at 7:32 AM
EyeGate Pharma Completes Randomization in Pivotal StudyEyeGate Pharma Completes Randomization in Pivotal Study
finance.yahoo.com - October 9 at 7:32 AM
EyeGate Pharma Enrolls First Patient in Follow-on PE Pilot StudyEyeGate Pharma Enrolls First Patient in Follow-on PE Pilot Study
finance.yahoo.com - October 9 at 7:32 AM
Armistice Capital Master Fund Buys 605,001 Shares of Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) StockArmistice Capital Master Fund Buys 605,001 Shares of Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) Stock
www.americanbankingnews.com - October 2 at 1:11 PM
BRIEF-EyeGate Enters Into Securities Purchase Agreement With Armistice Capital Master FundBRIEF-EyeGate Enters Into Securities Purchase Agreement With Armistice Capital Master Fund
www.msn.com - September 30 at 10:21 PM
EyeGate Enters Into Agreement for $1.9 Million Private PlacementEyeGate Enters Into Agreement for $1.9 Million Private Placement
finance.yahoo.com - September 30 at 5:21 PM
EyeGate Pharmaceuticals, Inc.: EyeGate Pharma Regains Nasdaq Listing ComplianceEyeGate Pharmaceuticals, Inc.: EyeGate Pharma Regains Nasdaq Listing Compliance
www.finanznachrichten.de - September 23 at 9:45 AM
EyeGate Pharma Regains Nasdaq Listing ComplianceEyeGate Pharma Regains Nasdaq Listing Compliance
finance.yahoo.com - September 23 at 9:45 AM
EyeGate Pharmaceuticals, Inc.: EyeGate Pharma Reaches 75% Randomization of Patients in Pivotal StudyEyeGate Pharmaceuticals, Inc.: EyeGate Pharma Reaches 75% Randomization of Patients in Pivotal Study
www.finanznachrichten.de - September 16 at 11:07 AM
EyeGate Pharma Reaches 75% Randomization of Patients in Pivotal StudyEyeGate Pharma Reaches 75% Randomization of Patients in Pivotal Study
finance.yahoo.com - September 16 at 11:07 AM
EyeGate Pharmaceuticals, Inc.: EyeGate Pharma to Present at H.C. Wainwright 21st Annual Global Investment ConferenceEyeGate Pharmaceuticals, Inc.: EyeGate Pharma to Present at H.C. Wainwright 21st Annual Global Investment Conference
www.finanznachrichten.de - September 3 at 8:48 AM
EyeGate Pharma to Present at H.C. Wainwright 21st Annual Global Investment ConferenceEyeGate Pharma to Present at H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 3 at 8:48 AM
EyeGate Pharma Announces Reverse Stock Split...EyeGate Pharma Announces Reverse Stock Split...
www.benzinga.com - August 29 at 8:12 PM
EyeGate Pharma Announces Reverse Stock Split Effective August 30, 2019EyeGate Pharma Announces Reverse Stock Split Effective August 30, 2019
finance.yahoo.com - August 29 at 8:12 PM
EyeGate Pharmaceuticals, Inc.: EyeGate Pharma Reaches 50% Randomization of Patients in Pivotal StudyEyeGate Pharmaceuticals, Inc.: EyeGate Pharma Reaches 50% Randomization of Patients in Pivotal Study
www.finanznachrichten.de - August 26 at 8:24 AM
EyeGate Pharma Reaches 50% Randomization of Patients in Pivotal StudyEyeGate Pharma Reaches 50% Randomization of Patients in Pivotal Study
finance.yahoo.com - August 26 at 8:24 AM
Global Ophthalmic Drugs Sales Market By Current Industry Status, Growth Opportunities, Top Key Players, Target Audience And Forecast To 2025Global Ophthalmic Drugs Sales Market By Current Industry Status, Growth Opportunities, Top Key Players, Target Audience And Forecast To 2025
www.marketwatch.com - August 12 at 1:30 PM
EyeGate Pharma Reports Second Quarter 2019 Financial Results and Provides Business UpdateEyeGate Pharma Reports Second Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - August 8 at 9:32 AM
dry eyesdry eyes
www.benzinga.com - August 5 at 11:40 PM
Eyegate Pharmaceuticals Receives FDA Approval To Begin PE Pilot StudyEyegate Pharmaceuticals Receives FDA Approval To Begin PE Pilot Study
feeds.benzinga.com - August 5 at 9:21 AM
U.S. STOCKS ON THE MOVE-GlycoMimetics, Diamond Offshore, Eyegate PharmaceuticalsU.S. STOCKS ON THE MOVE-GlycoMimetics, Diamond Offshore, Eyegate Pharmaceuticals
www.nasdaq.com - August 5 at 9:09 AM
FDA approves EyeGate Pharmas PE pilot study; shares up 14% premarketFDA approves EyeGate Pharma's PE pilot study; shares up 14% premarket
seekingalpha.com - August 5 at 9:09 AM
EyeGate Pharma Receives Approval from FDA to Initiate PE Pilot StudyEyeGate Pharma Receives Approval from FDA to Initiate PE Pilot Study
finance.yahoo.com - August 5 at 9:09 AM
EyeGate Pharma Announces Randomization of First 25% of Patients in Pivotal StudyEyeGate Pharma Announces Randomization of First 25% of Patients in Pivotal Study
finance.yahoo.com - July 31 at 9:25 AM
EyeGate to start OBG pilot study for PE; shares up 14% premarketEyeGate to start OBG pilot study for PE; shares up 14% premarket
seekingalpha.com - July 9 at 6:42 PM
EyeGate Pharmaceuticals, Inc.: EyeGate Files FDA Submission to Initiate PE Pilot StudyEyeGate Pharmaceuticals, Inc.: EyeGate Files FDA Submission to Initiate PE Pilot Study
www.finanznachrichten.de - July 9 at 8:23 AM
EyeGate Files FDA Submission to Initiate PE Pilot StudyEyeGate Files FDA Submission to Initiate PE Pilot Study
finance.yahoo.com - July 9 at 8:23 AM
EyeGate Announces First Patient Enrolled in PRK Pivotal StudyEyeGate Announces First Patient Enrolled in PRK Pivotal Study
finance.yahoo.com - June 26 at 6:41 PM
EyeGate Pharmaceuticals, Inc.: EyeGate Announces First Patient Enrolled in PRK Pivotal StudyEyeGate Pharmaceuticals, Inc.: EyeGate Announces First Patient Enrolled in PRK Pivotal Study
www.finanznachrichten.de - June 26 at 8:26 AM
EYEG: FDA Approves IDE. We Like Chances of Success of Upcoming OBG-PRK Pivotal StudyEYEG: FDA Approves IDE. We Like Chances of Success of Upcoming OBG-PRK Pivotal Study
finance.yahoo.com - June 5 at 6:57 PM
EyeGate Pharmaceuticals, Inc.: EyeGate Receives Approval from FDA to Initiate PRK Pivotal StudyEyeGate Pharmaceuticals, Inc.: EyeGate Receives Approval from FDA to Initiate PRK Pivotal Study
www.finanznachrichten.de - June 3 at 8:18 AM
EyeGate up 59% premarket on FDA approval to initiate PRK studyEyeGate up 59% premarket on FDA approval to initiate PRK study
seekingalpha.com - June 3 at 8:18 AM
EyeGate Receives Approval from FDA to Initiate PRK Pivotal StudyEyeGate Receives Approval from FDA to Initiate PRK Pivotal Study
finance.yahoo.com - June 3 at 8:18 AM
EyeGate Pharmaceuticals, Inc.: EyeGate Pharma Receives Positive Nasdaq Listing DeterminationEyeGate Pharmaceuticals, Inc.: EyeGate Pharma Receives Positive Nasdaq Listing Determination
www.finanznachrichten.de - May 14 at 8:40 AM
EyeGate Pharma Receives Positive Nasdaq Listing DeterminationEyeGate Pharma Receives Positive Nasdaq Listing Determination
finance.yahoo.com - May 14 at 8:40 AM
EyeGate Pharmaceuticals, Inc.: EyeGate Pharma Reports First Quarter 2019 Financial Results and Provides Business UpdateEyeGate Pharmaceuticals, Inc.: EyeGate Pharma Reports First Quarter 2019 Financial Results and Provides Business Update
www.finanznachrichten.de - May 8 at 7:37 PM
EyeGate Pharma Reports First Quarter 2019 Financial Results and Provides Business UpdateEyeGate Pharma Reports First Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - May 8 at 7:37 PM
Eyegate Pharmaceuticals Inc.Eyegate Pharmaceuticals Inc.
www.barrons.com - May 3 at 7:14 PM
EyeGate Pharmaceuticals, Inc.: EyeGate Files IDE with FDA for PRK Pivotal StudyEyeGate Pharmaceuticals, Inc.: EyeGate Files IDE with FDA for PRK Pivotal Study
www.finanznachrichten.de - May 2 at 8:00 PM
EYEG: EYEG Submits IDE to FDA Seeking Approval to Commence Pivotal PRK StudyEYEG: EYEG Submits IDE to FDA Seeking Approval to Commence Pivotal PRK Study
finance.yahoo.com - May 2 at 8:00 PM
EyeGate Files IDE with FDA for PRK Pivotal StudyEyeGate Files IDE with FDA for PRK Pivotal Study
finance.yahoo.com - May 2 at 8:25 AM
EYEG: Our Take On EYEG Moving Towards OBG-PRK Pivotal StudyEYEG: Our Take On EYEG Moving Towards OBG-PRK Pivotal Study
finance.yahoo.com - March 28 at 7:26 PM
EyeGate confirms path to de novo filing for OBGEyeGate confirms path to de novo filing for OBG
seekingalpha.com - March 26 at 7:43 PM
EyeGate Pharmaceuticals, Inc.: EyeGate Confirms Path to De Novo Filing with FDAEyeGate Pharmaceuticals, Inc.: EyeGate Confirms Path to De Novo Filing with FDA
www.finanznachrichten.de - March 26 at 8:31 AM
EyeGate Confirms Path to De Novo Filing with FDAEyeGate Confirms Path to De Novo Filing with FDA
finance.yahoo.com - March 26 at 8:31 AM
EyeGate Pharmaceuticals IncEyeGate Pharmaceuticals Inc
www.bloomberg.com - March 19 at 8:37 AM
Eyegate Pharmaceuticals, Inc. Estimate MomentumEyegate Pharmaceuticals, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 8:01 PM
EyeGate Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Business UpdateEyeGate Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Business Update
finance.yahoo.com - March 1 at 7:04 PM
EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York CityEyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City
finance.yahoo.com - January 29 at 8:14 AM
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: Blockchain

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel